Federal contractor profile
UEI Z1L9F1MM1RY3CAGE 2H173Company website ↗
CHILDREN'S HOSPITAL CORPORATION, THE is associated with UEI Z1L9F1MM1RY3 and CAGE 2H173 in public federal records. AcornBids currently links 10 prime awards totaling $102.4M in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Research and Development in Biotechnology (except Nanobiotechnology); Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology); All Other Professional, Scientific, and Technical Services. These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 622310 (Specialty (except Psychiatric and Substance Abuse) Hospitals). Its public SAM.gov registration lists BOSTON, MA, USA.
Detailed agency totals are not available in this stored profile.
Largest positive coded-agency total ÷ all positive coded-agency totals × 100
Missing data is shown as unavailable.
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Sep 28, 2026. Refresh pending; these totals may be out of date.
Public SAM.gov registration details.
Net transaction obligations by federal fiscal period.
Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| 36C24126P0652PTSD SAMPLE BIOMARKERS TESTING | Department of Veterans Affairs | $64.9K | Sep 28, 2026 | Sep 27, 2027 |
| 75N93023C00040VACCINES ADJUVANT DEVELOPMENT PROGRAM IN INFECTIOUS AND IMMUNE MEDIATED DISEASES | Department of Health and Human Services | $6.0M | Sep 30, 2023 | Sep 29, 2028 |
| 75N93024C00020VACCINE ADJUVANT DISCOVERY PROGRAM (VADP) | Department of Health and Human Services | $2.5M | Sep 30, 2024 | Sep 29, 2029 |
| 75N93020C00038TO DEVELOP INNOVATIVE AND SAFE MULTIVALENT ANTI-OPIOID VACCINES THAT PROTECT AGAINST HEROIN AND FENTANYL. | Department of Health and Human Services | $19.9M | Sep 30, 2020 | Sep 29, 2027 |
| 75D30122C13330COVID-19 & MIS-C VE STUDY | Department of Health and Human Services | $24.9M | Aug 3, 2022 | Sep 15, 2026 |
| 75N93019C00044TO IDENTIFY NOVEL ADJUVANT CANDIDATES THAT CAN BE USED TO AUGMENT THE EFFICACY OF HUMAN VACCINES. | Department of Health and Human Services | $11.0M | Sep 30, 2019 | Dec 29, 2025 |
| 75N93018C00047IGF::OT::IGF ADJUVANT DEVELOPMENT PROGRAM | Department of Health and Human Services | $13.6M | Sep 30, 2018 | Nov 29, 2025 |
| 75D30123C15938COMMUNITY FINDER PLATFORM | Department of Health and Human Services | $27.9M | Feb 1, 2023 | Jul 31, 2025 |
| 75P00122P00130BASE YEAR - MOTHER-INFANT DYAD PROJECT | Department of Health and Human Services | $450.0K | Sep 30, 2022 | Sep 29, 2025 |
| 75D30123C16026SCIENTIFIC STUDY | Department of Health and Human Services | $3.6M | Mar 31, 2023 | Mar 30, 2025 |
Modeled recompete windows are estimates, not announced solicitations or guarantees.
| Registration evidence | Date |
|---|---|
| SAM updated | Dec 4, 2025 |
| Source loaded | Sep 26, 2026 |
| Initial registration | Feb 7, 2002 |
| Entity start | Jul 1, 1869 |
| Industry | Reported size status |
|---|---|
| 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Not reported |
| 622310 — Specialty (except Psychiatric and Substance Abuse) Hospitals | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| PAUL SANTOS | Government business | Contact method not published | SAM registration | Not available |
| TEE TRAC | Alternate government business | Contact method not published | SAM registration | Not available |
| PAUL SANTOS | Electronic business | Contact method not published | SAM registration | Not available |
| TEE TRAC | Alternate electronic business | Contact method not published | SAM registration | Not available |
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Explore the customer, work and award-size evidence behind each match.
Recorded award industries: 541714 — Research and Development in Biotechnology (except Nanobiotechnology); 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology); 541990 — All Other Professional, Scientific, and Technical Services.
Recorded products and services: AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH; AN41 — HEALTH R&D SERVICES; HEALTH CARE - OTHER; BASIC RESEARCH; AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH.
Examples from recent award records:
These records describe federal award work, not every company capability. Review the award evidence.
300 LONGWOOD AVE, BOSTON, Massachusetts 02115, United States
Registered location from SAM.gov; award performance locations may differ.
622310 — Specialty (except Psychiatric and Substance Abuse) Hospitals.
Primary SAM.gov NAICS classification.
Department of Health and Human Services; Department of Veterans Affairs.
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
No official subaward rows are loaded, so Acorn does not claim known teaming relationships.
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit